Candel Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +0.0% | +0.0% | +0.0% | -75.2% | -100.0% | – | |
| – | – | – | +325.4% | +2,329.6% | -95.9% | -14.6% | |
| – | +0.0% | +0.0% | +0.0% | -19,284.0% | – | – | |
| – | +32.5% | +73.4% | +37.0% | +17.9% | -21.2% | +57.9% | |
| – | +102.8% | +106.0% | +31.7% | -1.2% | +1.2% | +26.4% | |
| – | +52.1% | +85.5% | +34.6% | +10.3% | -13.1% | +44.6% | |
| – | – | – | – | – | – | – | |
| – | -89.6% | -52.3% | +3,122.6% | +51.9% | -19.5% | +1.4% | |
| – | – | – | – | – | – | – | |
| – | – | +131.4% | -253.2% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.